Health professional reported that post implantation of seri during a breast reduction surgery, pt presented with device "palpability and skin breakdown." seri device was fully explanted.During explant surgery, physician noted "expected incorporation of seri in areas where the product was flat against tissue, but in areas where seri was "bunched up", [physician] felt it had not incorporated well and was a problem." physician considers the non-incorporation to be "related to the technique [physician] used to place seri in which the 25 cm length of the product was placed in the cephalad-caudal direction spanning the nipple-areolar complex to support the breast." physician additionally reported: "developed non-healing wounds and exposure of [seri] 6 weeks post implantation.".
|
Further info from the reported regarding product details has been requested.No additional info is available at this time.The events of "palpability, skin breakdown, non-healing wounds, and exposure" are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.The physician discarded the device when it was explanted and it is no longer available for return.Therefore allergan will not receive it and no analysis or testing will be done.Device labeling addresses the event of extrusion.These events are being reported because med interventions was required, although device-relatedness has not been established.
|